Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Hyderabad(28)
- Gujarat(33)
- Pune(7)
- Bangalore(3)
- Maharashtra(42)
- Mumbai(53)
- Delhi(14)
- New Delhi(4)
- Vadodara(7)
- Beijing(2)
- Karnataka(8)
- Haryana(3)
- Tamil Nadu(4)
- Rajasthan(1)
- Kolkata(1)
- Punjab(4)
- Andhra Pradesh(2)
- Ahmedabad(12)
- Uttar Pradesh(5)
- Telangana(3)
- West Bengal(1)
- Kerela(1)
- Madhya Pradesh(2)
- Nagpur(2)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- N/A
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.9 percent
- 99.86%
- 99.85%
- 99.80%
- 99.77%
- 99.73%
- 99.66%
- 99.65%
- 99.60%
- 99.50%
- >99.5%
- 99.5%
- 99.42%
- 99.29%
- 99.24%
- >99%
- > 99%
- 99%
- 99 %
- 98+
- 98.70%
- 98.67%
- 98.60%
- 98.50 -101.5 %
- 98.12%
- 98.00%
- 98% min
- >98%
- 98%
- 98 %
- 97-99%
- 97.57%
- 97.23%
- 97.00%
- 97%
- >97%
- 97 %
- 96.80%
- 96.39%
- 96%
- 95.00%
- >95%
- 95%
- 94.00%
- 93.09%
- 92.52%
- >92%
- 90%-95%
- >90%
- 90%
- 90 % Above
- 84.49%
- 80 %
- 6%
- 50%
- 50
- 35%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 225%
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1g
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 500ml
- 1kg
- 2500ml
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1R,2R,3S,5R)-rel-
2216753-87-4
-
AR-C 124910XX
220347-05-7
-
1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
2417798-14-0
-
ethyCyclopropanamine, 2-(3,4-difluorophenyl)-, (1R,2S)- (REACH)
220352-38-5
-
Ticagrelor Related Compound 68 Oxalate
2165799-36-8
-
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaMine hydrochloride
1402222-66-5
-
AzithroMycin iMpurity I
-
Gabapentine Impurity 72
433707-84-7
-
N'-DesMethyl AzithroMycin
172617-84-4
-
Defluoro Atorvastatin
433289-84-0
TICAGRELOR EP IMPURITY E 220352-38-5
99% Azithromycin Impurity I 172617-84-4 API Powder, Lab Grade 172617-84-4
Atorvastatin ep impurity A 433289-84-0
Diethyl phthalate 84-66-2
Reactive Orange 84 91261-29-9
Diisobutyl phthalate 84-69-5
2-Hydroxy-5-(methylsulfanyl)benzaldehyde 67868-84-2
Reactive Blue 13 12236-84-9
(SP-4-1)-dichlorobis[1,1'-thiobis[ethane]]-Platinum 15337-84-5